PMID: 6976792Dec 1, 1981Paper

Specific and non-specific lymphocyte cytotoxicity in colon carcinoma

British Journal of Cancer
B M VoseP F Schofield

Abstract

The cytotoxic activity of peripheral-blood (PBL), lymph-node (LNC) and tumour-infiltrating lymphocytes (TIL) from 47 patients undergoing surgery for colon carcinoma (Duke's Stage A, 1 patient; B, 24; C, 15 and C with metastases, 7) was examined in short-term 51Cr-release assays, against fresh autologous tumour cells, allogeneic colon cancer cells and the erythroleukaemia cell line, K562. Cytotoxicity against autologous cells was detected in at least one effector population in 23/47 patients (49%), with overall frequencies which did not differ for patients in different Duke's stages of disease. By contrast, lysis of allogeneic tumour cells was infrequent (11%) regardless of the effector population to which they were exposed. Cytotoxicity against K562, cells highly sensitive to NK activity, though variable, was detected in 93% of PBL of normal donors and 83% of patients, and among the latter showed no evidence of significant decline with advancing disease. However, LNC and TIL anti-K562 activity was infrequent (17%) in concordance with previous reports. There was no correlation between the ability of patients' PBL to lyse autologous tumour and K562 cells. The independence of these 2 cytotoxic actions was further explored in studi...Continue Reading

Citations

Jan 1, 1990·Journal of Clinical Laboratory Analysis·D S GridleyD R Stickney
Aug 1, 1987·The British Journal of Surgery·P J Guillou
Oct 1, 1982·Journal of Clinical Immunology·J C Roder, H F Pross
Jul 30, 1992·International Journal of Cancer. Journal International Du Cancer·B T PatelV Schirrmacher
Jul 1, 1988·Journal of Surgical Oncology·H YaitaK Nomoto
Jul 1, 1993·Cancer Immunology, Immunotherapy : CII·A Uchida
Jan 1, 1988·Annals of the New York Academy of Sciences·J H FinkeJ Montie
Jan 1, 1989·Cancer Immunology, Immunotherapy : CII·G GuantiI Giorgio
Aug 2, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Simon TurcotteSteven A Rosenberg
Jan 1, 1989·Cancer Immunology, Immunotherapy : CII·T Mainou-Fowler, O Eremin
Aug 1, 1996·Hematology/oncology Clinics of North America·D Y Kavanaugh, D P Carbone
Oct 1, 1986·Journal of Maxillofacial Surgery·K Vinzenz, M Micksche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
R S LeeE Tartour
© 2021 Meta ULC. All rights reserved